Abstract:Background: Fibroblast activation protein (FAP) is a cell-surface serine protease that has both dipeptidyl peptidase as well as endopeptidase activities and could cleave substrates at post-proline bond. Previous findings showed that FAP was hard to be detected in normal tissues but significantly up-regulated in remodeling sites like fibrosis, atherosclerosis, arthritis and embryonic tissues. Though increasing evidence has demonstrated the importance of FAP in cancer progression, no multifactorial analysis has been developed to investigate its function in gastrointestinal cancers until now. Methods: By comprehensive use of datasets from The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), scTIME Portal and Human Protein Atlas (HPA), we evaluated the carcinogenesis potential of FAP in gastrointestinal cancers, analyzing the correlation between FAP and poor outcomes, immunology in liver, colon, pancreas as well as stomach cancers. Then liver cancer was selected as example to experimentally validate the pro-tumor and immune regulative role of FAP in gastrointestinal cancers. Results: FAP was abundantly expressed in gastrointestinal cancers, such as LIHC, COAD, PAAD and STAD. Functional analysis indicated that the highly-expressed FAP in these cancers could affect extracellular matrix organization process and interacted with genes like COL1A1, COL1A2, COL3A1 and POSTN. In addition, it was also observed that FAP was positively correlated to M2 macrophages infiltration across these cancers. To verify these findings in vitro , we used LIHC as example and over-expressed FAP in human hepatic stellate LX2 cells, a main cell type that produce FAP in tumor tissues, and then investigate its role on LIHC cells as well as macrophages. Results showed that the medium from FAP-over-expressed LX2 cells could significantly promote the motility of MHCC97H and SK-Hep1 LIHC cells, increase the invasion of THP-1 macrophages and induce them into pro-tumor M2 phenotype. Conclusion: In summary, we employed bioinformatic tools and experiments to perform a comprehensive analysis about FAP. Up-regulation of FAP in gastrointestinal cancers was primarily expressed in fibroblasts and contributes to tumor cells motility, macrophages infiltration and M2 polarization, revealing the multifactorial role of FAP in gastrointestinal cancers progression.

Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment

Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy

Fibroblast activation protein-based theranostics in pancreatic cancer

[Progress on Cancer Associated Fibroblasts in Tumor Immunoregulation].

Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy

A multifactorial analysis of FAP to regulate gastrointestinal cancers progression

Fibroblast Activation Protein-Targeted Radioligand Therapy in Various Types of Cancer: Background, Clinical Studies, and Future Development

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors

FAP-α (fibroblast Activation Protein-Α) is Involved in the Control of Human Breast Cancer Cell Line Growth and Motility Via the FAK Pathway

Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways

Promotion of Cellular Growth and Motility is Independent of Enzymatic Activity of Fibroblast Activation Protein-α.

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies

The recent advances of cancer associated fibroblasts in cancer progression and therapy

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer

High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes

Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities